List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 4 studies with search of: anti-CD74
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
Conditions: Non-Hodgkin's Lymphoma;   Chronic Lymphocytic Leukemia
Intervention: Drug: hLL1
2 Recruiting Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in NHL/CLL
Conditions: Non-Hodgkin's Lymphoma;   Chronic Lymphocytic Lymphoma
Intervention: Biological: milatuzumab
3 Recruiting Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Condition: Lymphoma
Interventions: Biological: milatuzumab;   Biological: veltuzumab;   Other: laboratory biomarker analysis;   Other: pharmacological study
4 Recruiting The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Milatuzumab

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services